EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alpha-Ketoglutarate Regulates Tnfrsf12a/Fn14 Expression via Histone Modification and Prevents Cancer-Induced Cachexia

Bryan I Ruiz, Xazmin H Lowman, Ying Yang, Qi Fan, Tianhong Wang, Hongmei Wu, Eric A Hanse, Mei Kong

Genes · 2023

DOI: 10.3390/genes14091818 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2023. Verfasst von Bryan I Ruiz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, CA 92697, USA. Hauptthemen laut MEDLINE: Cachexia, Colonic Neoplasms, TWEAK Receptor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Science Foundation Graduate Research Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous studies have shown that inhibition of TNF family member FN14 (gene: TNFRSF12A) in colon tumors decreases inflammatory cytokine expression and mitigates cancer-induced cachexia. However, the molecular mechanisms underlying the regulation of FN14 expression remain unclear. Tumor microenvironments are often devoid of nutrients and oxygen, yet how the cachexic response relates to the tumor microenvironment and, importantly, nutrient stress is unknown. Here, we looked at the connections between metabolic stress and FN14 expression. We found that TNFRSF12A expression was transcriptionally induced during glutamine deprivation in cancer cell lines. We also show that the downstream glutaminolysis metabolite, alpha-ketoglutarate (aKG), is sufficient to rescue glutamine-deprivation-promoted TNFRSF12A induction. As aKG is a co-factor for histone de-methylase, we looked at histone methylation and found that histone H3K4me3 at the Tnfrsf12a promoter is increased under glutamine-deprived conditions and rescued via DM-aKG supplementation. Finally, expression of Tnfrsf12a and cachexia-induced weight loss can be inhibited in vivo by DM-aKG in a mouse cancer cachexia model. These findings highlight a connection between metabolic stress and cancer cachexia development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaColonic NeoplasmsTWEAK ReceptorAnimalsMiceDisease Models, AnimalGlutamineHistone CodeHistone MethyltransferasesHistonesKetoglutaric AcidsTumor MicroenvironmentHumansCell Line, Tumor

Stichwörter der Autor:innen

FN14TNFRSF12Aalpha-ketoglutaratecachexiacancercolon cancerhistone

Substanzen

GlutamineHistone MethyltransferasesHistonesKetoglutaric AcidsTNFRSF12A protein, humanTnfrsf12a protein, mouseTWEAK Receptor

Autor:innen und Institutionen

  • Department of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, CA 92697, USA.

Förderung

  • NCI NIH HHS
  • National Science Foundation Graduate Research Fellowship

Zitieren

APA

Ruiz, B. I., Lowman, X. H., Yang, Y., Fan, Q., Wang, T., Wu, H., Hanse, E. A., & Kong, M. (2023). Alpha-Ketoglutarate Regulates Tnfrsf12a/Fn14 Expression via Histone Modification and Prevents Cancer-Induced Cachexia. Genes. https://doi.org/10.3390/genes14091818

Vancouver

Ruiz BI, Lowman XH, Yang Y, Fan Q, Wang T, Wu H, et al. Alpha-Ketoglutarate Regulates Tnfrsf12a/Fn14 Expression via Histone Modification and Prevents Cancer-Induced Cachexia. Genes. 2023. doi:10.3390/genes14091818

BibTeX
@article{Ruiz2023,
  author = {Ruiz, Bryan I and Lowman, Xazmin H and Yang, Ying and Fan, Qi and Wang, Tianhong and Wu, Hongmei and Hanse, Eric A and Kong, Mei},
  title = {Alpha-Ketoglutarate Regulates Tnfrsf12a/Fn14 Expression via Histone Modification and Prevents Cancer-Induced Cachexia},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14091818}
}
Kostenlos starten →